1. Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999). Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. International Journal of Geriatric Psychiatry, 14(10), 866–874. https://doi.org/10.1002/(SICI)1099-1166(199910)14:10<866::AID- GPS38>3.0.CO;2-Z 2. Atkinson-Clement, C., Sadat, J., & Pinto, S. (2015). Behavioral treatments for speech in Parkinson’s disease: meta-analyses and review of the literature. Neurodegenerative Disease Management, 5(3), 233–248. https://doi.org/10.2217/nmt.15.16 3. Bennett, G. (2017). The science of singing : A voice lesson from anatomy and physiology (pp. 0–15). Cedarville University. Retrieved from https://digitalcommons.cedarville.edu/research_scholarship_symposium/2017/ podium_presentations/1/ 4. Branchi, I., D’Andrea, I., Armida, M., Cassano, T., Pezzola, A., Potenza, R. L., Morgese, M. G, Popoli, P., Alleva, E. (2008). Nonmotor symptoms in Parkinson’s disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model. Journal of Neuroscience Research, 86(9), 2050–2061. https://doi.org/10.1002/jnr.21642 5. Buetow, S. A., Talmage, A., McCann, C., Fogg, L., & Purdy, S. (2014). Conceptualizing how group singing may enhance quality of life with Parkinson’s disease. Disability and Rehabilitation, 36(5), 430–433. https://doi.org/10.3109/09638288.2013.793749 6. Cacciatore, F. M., Simone, D. De, Patrocinio, D., & Sallustio, V. (2012). Adverse drug reaction to dopamine agonists (DA) or appearance of a typical sign of Parkinson’s Disease induced by DA. Basal Ganglia, 2(3), e1–e87. https://doi.org/10.1016/j.baga.2012.10.001 7. Clark, J. P., Adams, S. G., Dykstra, A. D., Moodie, S., & Jog, M. (2014). Loudness perception and speech intensity control in Parkinson’s disease. Journal of Communication Disorders, 51, 1–12. https://doi.org/10.1016/j.jcomdis.2014.08.001 8. Dyduch, A., & Załuska, M. (2014). Depression in Parkinson’s disease: the effectiveness and risk of pharmacotherapy. Clinical review. Psychogeriatrics : The Official Journal of the Japanese Psychogeriatric Society, 1–7. https://doi.org/10.1111/psyg.12078 9. Elefant, C., Baker, F. a, Lotan, M., Lagesen, S. K., & Skeie, G. O. (2012). The Effect of Group Music Therapy on Mood, Speech, and Singing in Individuals with Parkinson’s Disease -- A Feasibility Study. Journal of Music Therapy, 49(3), 278–302. https://doi.org/10.1093/jmt/49.3.278 10. Elefant, C., Lotan, M., Baker, F. a., & Skeie, G. O. (2012). Effects of music therapy on facial expression of individuals with Parkinson’s disease: A pilot study. Musicae Scientiae, 16(3), 392–400. https://doi.org/10.1177/1029864912458917 11. Evans, C., Canavan, M., Foy, C., Langford, R., & Proctor, R. (2012). Can group singing provide effective speech therapy for people with Parkinson’s disease? Arts & Health, 4(1), 83–95. https://doi.org/10.1080/17533015.2011.584883 12. Fogg-Rogers, L., Buetow, S., Talmage, A., McCann, C. M., Leao, S. H. S., Tippett, L., Leung, J., McPherson, K. M., Purdy, S. C. (2015). Choral singing therapy following stroke or Parkinson’s disease: An exploration of participants’ experiences. Disability and Rehabilitation, 8288(November), 1–11. https://doi.org/10.3109/09638288.2015.1068875 13. Haneishi, E. (2001). Effects of a music therapy voice protocol on speech intelligibility, vocal acoustic measures, and mood of individuals with Parkinson’s disease. Journal of Music Therapy, 38(4), 273–290. https://doi.org/10.1093/jmt/38.4.273 14. Jankovic, J. (2008). Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 79(4), 368–376. https://doi.org/10.1136/jnnp.2007.131045 15. Jenkinson, C., Peto, V., Fitzpatrick, R., Greenhall, R., Hyman, N. (1995) Self- reported Functioning and Well-being in Patients with Parkinson's Disease: Comparison of the Short-form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age and Ageing, 24, 505-509. 16. Lim, S.-Y., Fox, S. H., & Lang, A. E. (2009). Overview of the extranigral aspects of Parkinson disease. Archives of Neurology, 66(2), 167–172. https://doi.org/10.1001/archneurol.2008.561 17. Lim, S.-Y., Puvanarajah, S., Lee, M. K., Chee, K. Y., Viswanathan, S., Tan, A. H., Chong, K. T., Azrin, K. (2012). 2012 Consensus Guidelines for the Treatment of Parkinson’s Disease. 18. Meireles, J., & Massano, J. (2012). Cognitive impairment and dementia in Parkinson’s disease: Clinical features, diagnosis, and management. Frontiers in Neurology, MAY(May), 1–16. https://doi.org/10.3389/fneur.2012.00088 19. Miller, N., Deane, K. H. O., Jones, D., Noble, E., & Gibb, C. (2011). National survey of speech and language therapy provision for people with Parkinson’s disease in the United Kingdom: Therapists’ practices. International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists, 46(2), 189–201. https://doi.org/10.3109/13682822.2010.484849 20. Miller, N., Noble, E., Jones, D., & Burn, D. (2006). Life with communication changes in Parkinson’s disease. Age and Ageing, 35(3), 235–239. https://doi.org/10.1093/ageing/afj053 21. Pabon, P., Stallinga, R., Södersten, M., & Ternström, S. (2014). Effects on vocal range and voice quality of singing voice training: The classically trained female voice. Journal of Voice, 28(1), 36–51. https://doi.org/10.1016/j.jvoice.2013.06.005 22. Pacchetti, C., Mancini, F., Aglieri, R., Fundarò, C., Martignoni, E., & Nappi, G. (2000). Active music therapy in Parkinson’s disease: An integrative method for motor and emotional rehabilitation. Psychosomatic Medicine, 62, 386–393. https://doi.org/10.1097/00006842-200005000-00012 23. Pagonabarraga, J., Kulisevsky, J., Strafella, A. P., & Krack, P. (2015). Apathy in Parkinson’s disease: Clinical features, neural substrates, diagnosis, and treatment. The Lancet Neurology, 14(5), 518–531. https://doi.org/10.1016/S1474-4422(15)00019-8 24. Pinto, S., Ozsancak, C., Tripoliti, E., Thobois, S., Limousin-dowsey, P., & Auzou, P. (2004). Review treatments for dysarthria in Parkinson ’ s disease. Neurology, 3(September), 547–556. 25. Politis, M., Wu, K., Molloy, S., Bain, P. G., Chaudhuri, K. R., & Piccini, P. (2010). Parkinson’s disease symptoms: The patient’s perspective. Movement Disorders, 25(11), 1646–1651. https://doi.org/10.1002/mds.23135 26. Ramig, L., & Fox, C. (2007). Speech disorders in Parkinson’s disease and the effects of pharmacological, surgical and speech treatment with emphasis on Lee Silverman voice treatment (LSVT). Parkinson’s Disease Foundation News and Review. 27. Ramig, L. O., Fox, C., & Sapir, S. (2007). Speech disorders in Parkinson’s disease and the effects of pharmacological, surgical and speech treatment with emphasis on Lee Silverman voice treatment (LSVT). Handbook of Clinical Neurology (Vol. 83, pp. 385–399). https://doi.org/10.1016/S0072- 9752(07)83017-X 28. Richardson, K., Sussman, J. E., Stathopoulos, E. T., & Huber, J. E. (2014). The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: A preliminary analysis. Journal of Communication Disorders, 52, 44–64. https://doi.org/10.1016/j.jcomdis.2014.09.004 29. Rutten, S., Ghielen, I., Vriend, C., Hoogendoorn, A. W., Berendse, H. W., Leentjens, A. F. G., … van den Heuvel, O. A. (2014). Anxiety in Parkinson’s disease: Symptom dimensions and overlap with depression and autonomic failure. Parkinsonism and Related Disorders. https://doi.org/10.1016/j.parkreldis.2014.11.019 30. Sataloff, R. T. (2015). Book Review: Singing and Science: Body, Brain and Voice. Journal of Voice, 29(1), e1. https://doi.org/10.1016/j.jvoice.2014.06.010 31. Schulz, G. M., & Grant, M. K. (2000). Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson’s disease: A review of the literature. Journal of Communication Disorders, 33, 59–88. https://doi.org/10.1016/S0021-9924(99)00025-8 32. Schulz, G. M., Greer, M., & Friedman, W. (2000). Changes in vocal intensity in Parkinson’s disease following pallidotomy surgery. Journal of Voice:Official Journal of the Voice Foundation, 14(4), 589–606. https://doi.org/10.1016/S0892-1997(00)80015-6 33. Scott, S., & Caird, F. I. (1983). Speech therapy for Parkinson’ s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 46(October 1982), 140–144. Retrieved from http://jnnp.bmj.com/content/46/2/140.full.pdf+html 34. Tanday, S. (2016). Feature How the power of singing is helping patients to breathe again. The Lancet Respiratory, 2600(16), 2600. https://doi.org/10.1016/S2213- 2600(16)00002-3 35. Wertheimer, J., Gottuso, A. Y., Nuno, M., Walton, C., Duboille, A., Tuchman, M., & Ramig, L. (2014). The impact of STN deep brain stimulation on speech in individuals with Parkinson’s disease: The patient’s perspective. Parkinsonism and Related Disorders, 20(10), 1065–1070. https://doi.org/10.1016/j.parkreldis.2014.06.010